We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A phase I pharmacological and biological study of PI-88 and docetaxel in patients with advanced malignancies.
- Authors
Chow, Laura Q M; Gustafson, Daniel L; O'Bryant, Cindy L; Gore, Lia; Basche, Michele; Holden, Scott N; Morrow, Mark C; Grolnic, Stacy; Creese, Brian R; Roberts, Kaye L; Davis, Kat; Addison, Russell; Eckhardt, S Gail
- Abstract
This study evaluated the safety, toxicity, pharmacological properties and biological activity of PI-88, a heparanase endoglycosidase enzyme inhibitor, with fixed weekly docetaxel in patients with advanced solid malignancies.
- Publication
Cancer chemotherapy and pharmacology, 2008, Vol 63, Issue 1, p65
- ISSN
1432-0843
- Publication type
Journal Article
- DOI
10.1007/s00280-008-0712-z